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Liver and Pancreatic Resection in the Elderly
ABSTRACT
Fong, Y., Blumgart, L.H., Fortner, J.G and
Brennan, M.F (1995). Pancreatic or liver resection
for malignancy is safe and effective for the elderly.
Annals of Surgery, 222: 426-437.
Background: Liver resection, or pancreatico-
duodenectomy, has traditionally been thought
to have a high morbidity and. mortality rate
among the elderly. Recent improvements in
surgical and anesthetic techniques, an increas-
ing number of elderly patients, and an increas-
ing need to justify use of limited health care
resources prompted an assessment of recent
surgical outcomes.
Methods: Five hundred seventy-seven liver re-
sections (July 1985-July 1994) performed for
metastatic colorectal cancer and 488 pancreatic
resections (October 1983-July 1994) performed
for pancreatic malignancies were identified in
departmental data bases. Outcomes of patients
younger than age 70 years were compared with
those of patients age 70 years or older.
Results: Liver resection for 128 patients age 70
years or older resulted in a 4% perioperative.
mortality rate and a 42% complication rate.
Median hospital staywas 13 days, and 8% of the
patientsrequired admission to the intensive care
unit (ICU). Median survivalwas 40 months, and
the 5-year survival rate was 35%. No difference
were found between results for the elderly and
those for younger patients who had undergone
liver resection, except for a minimally shorter
hospital stayfortheyoungerpatients (median,12
days vs. 13 days p=0.003). Pancreatic resection
for 138 elderly patients resulted in a mortality
rate of 6% and a complication rate of 45%.
Median stay was 20 days, and 19% of the
patients required ICU admission, results iden-
tical to those for the younger cohort. Long-term
survival was poorer for the elderly patients,
with a 5-year survival rate of 21% compared
with 29% for the younger cohort (p=0.03).
Conclusions: Major liver or pancreatic resec-
tions can be performed for the elderly with
acceptable morbidity and mortality rates and
possible long-term survival. Chronologic age
alone is not a contraindication to liver or
pancreatic resection for malignancy.
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PAPER DISCUSION
In recent years, advances in surgical practice
have seen a reduction in morbidity and mortal-
ity rates for major hepatobiliary and pancreatic
resectional surgery. Given that surgical resection
is the only potential curative therapy for
malignant disease of the liver and pancreas,
many surgeons have advocated a more aggres-
sive approach to the management of such
malignancy in the anticipation of demonstrating
improved long-term survival. Whilst the title of
this paper from the Memorial Sloan-Kettering
Cancer Center might support a relaxation of
previously stringent selection criteria, the results
require close scrutiny before other surgeons rush
to follow suit and increase their own resectional
practice.
In the management of pancreatic cancer,
several recent series testify to the fact that
pancreaticoduodenectomy can be undertaken
with minimal mortality and low morbidity rates
[1, 2]. The authors report a creditable6% mortality
rate amongst the 138 patients over the age of 70
years undergoing pancreatic resection. The ope-
rative mortality rate was little different than for260 HPB INTERNATIONAL
those patients less than 70 years of age under-
going similar resections. Five year survival was
21%, although none of the 10 patients surviving to
five years underwent resection for pancreatic
adenocarcinoma. The careful selection of patients
for considerationofresection isexemplifiedbythe
fact that only 69 of the 138 patients undergoing
pancreatic resection had pancreatic adenocar-
cinoma. The intense demands placed on
hospital resource with such surgery is high-
lighted by the 45% complication rate and the
19% intensive care admission rate, although
median hospital stay was 20 days. There are no
data available to indicate whether recovery and
return to normal activity was different in
patients over 70 years of age and, as in
similarly reported series, there is no assessment
of the quality of life in patients following
discharge.
The authors do recognise the potential effect
of the pre-referral selection process in contribut-
ing to their good results. Further, it is noted that
the authors have adopted the use of laparoscopy
as a means of avoiding unnecessary laparotomy
[3]. Our own experience suggests that a
combination of laparoscopy and laparoscopic
ultrasonography will avoid unnecessary non-
therapeutic laparotomy [4], the morbidity of
which is not often appreciated from the publica-
tion of selected patients undergoing resectional
surgery. The median survival of 18 months
following pancreatic resection reported by the
authors merely serves to underline the impor-
tance of selecting out patients unlikely to benefit
from an aggressive surgical approach.
A more encouraging role for hepatic resection
in the management of colorectal metastases is
evident from a number of studies which have
demonstrated five year survival rates of up to
40% [5,6]. The present paper reports an encoura-
ging 35% five year survival rate which is not
dissimilar to the 39% five year survival rate
observed in patients under the age of 70 years.
Forty two percent of patients developed post-
operative complications and there was a 4%
peri-operative mortality rate. Male patients had
a greater risk for complication than female
patients and perhaps not surprisingly resection
of at least one lobe of the liver and operative
times exceeding four hours were associated
with increased risk. It is unfortunate that such
important factors of post-operative outcome
may not therefore be easily predicted before
patients are submitted to laparotomy. It is not
readily evident from other reported series as to
whether patients with other forms of hepatic
malignancy can be similarly considered for
resectional surgery with advancing years. Ope-
rative mortality rates as high as 41% have been
reported over the last ten years for patients
undergoing resection for primary hepatic ma-
lignancy [7, 8, 9].
It is evident that the authors are indeed able
to conclude that "patients with pancreatic or
liver malignancy should be considered for
surgical therapy regardless of chronologic
age". Nonetheless, it is apparent that assessment
of individual risk for patients undergoing resec-
tional surgery is not always possible. Relaxation
of existing criteria for considering patients for
complex hepatobiliary and pancreatic resection
should therefore only be undertaken in estab-
lished centres with a proven track record in this
specialist field of surgery.
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Pre-Liver Transplant: Tips Versus
Shunt
Distal Splenorenal
ABSTRACT
Abouljoud, M.S., Levy, M.F., Rees, C.R., Diamond,
N.G., Lee, S.P., Mulligan, D.C., Goldstein, R.M.,
Husberg, B., Gonwa, T.A. and Klintmalm, G.B.
(1995)A comparison of treatment with transjugular
intrahepatic portosystemic shunt or distal splenor-
enal shunt in the management of variceal bleeding
prior to liver transplantation. Transplantation, 59:
226-229.
Recurrent variceal bleeding in liver transplant
candidates with end-stage liver disease can
complicate or even prohibit a subsequent
transplant procedure (OLT). Endoscopic
sclero-therapy and medical therapy are consi-
dered as first-line management with surgical
shunts reserved for refractory situations. Surgi-
cal shunts can be associated with a high
mortality in this population and may compli-
cate subsequent OLT. The transjugular intra-
hepatic portosystemic shunt (TIPS) has been
recommended in these patients as a bridge to
OLT. This is a new modality that has not been
compared with previously established thera-
pies such as the distal splenorenal shunt
(DSRS). In this study we report our experience
with 35 liver transplant recipients who had a
previous TIPS (18 patients) or DSRS (17
patients) for variceal bleeding. The TIPS group
had a significantly larger proportion of criti-
cally ill and Child-Pugh C patients. Mean
operating time was more prolonged in the
DSRS group (P=0.014) but transfusion require-
ments were similar. Intraoperative portal vein
blood flow measurements averaged 2132+/-725
ml/min in the TIPS group compared with
1120+/-351ml/min in the DSRS group (P<0.001).
Arterial flows were similar. Mean ICU and
hospital stays were similar. There were 3
hospital mortalities in the DSRS group and
none in the TIPS group (P=0.1). We conclude
that TIPS is a valuable tool in the management
of recurrent variceal bleeding prior to liver
transplantation. Intra0Perative hemodynamic
measurements suggest a theoretical advantage
with TIPS. In a group of patients with advanced
liver disease we report an outcome that is
similar to patients treated with DSRS prior to
liver transplantation. The role of TIPS in the
treatment of nontransplant candidates remains
to be clarified.